Source: Eur Respir J 2011; 37: 1237-1247
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Borthwick L.A., Sunny S.S., Oliphant V., Perry J., Brodlie M., Johnson G.E., Ward C., Gould K., Corris P.A., De Soyza A., Fisher A.J.. Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway. Eur Respir J 2011; 37: 1237-1247

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Source: Eur Respir J 2008; 31: 1037-1045 Year: 2008 Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004 Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation? Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible? Year: 2006 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007 Bronchiolitis obliterans formation by epithelial-mesenchymal transition in lung transplant recipients Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010 Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004 Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans Source: International Congress 2016 – Orphan diseases I Year: 2016 Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004 Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008 Apoptosis and neutrophilic inflammation in airway remodeling in bronchiolitis obliterans Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018 Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003 Postinfection bronchiolitis obliterans in structure of chronic lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005 Hepatocyte growth factor (HGF) in lung allografts Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005